153 related articles for article (PubMed ID: 31148996)
1. Determinants of prostate specific antigen screening test uptake in an urban community in North-Central Nigeria.
Bello JO; Buhari T; Mohammed TO; Olanipekun HB; Egbuniwe AM; Fasiku OK; Wasiu R
Afr Health Sci; 2019 Mar; 19(1):1665-1670. PubMed ID: 31148996
[TBL] [Abstract][Full Text] [Related]
2. Knowledge of prostate cancer screening among native African urban population in Nigeria.
Ajape AA; Babata A; Abiola OO
Nig Q J Hosp Med; 2009; 19(3):145-7. PubMed ID: 20836318
[TBL] [Abstract][Full Text] [Related]
3. Knowledge of prostate cancer screening among native African urban population in Nigeria.
Ajape AA; Babata A; Abiola OO
Nig Q J Hosp Med; 2010; 20(2):94-6. PubMed ID: 21243859
[TBL] [Abstract][Full Text] [Related]
4. Knowledge, attitudes and screening practices regarding prostatic diseases among men older than 40 years: a population-based study in Southwest Nigeria.
Ojewola RW; Oridota ES; Balogun OS; Ogundare EO; Alabi TO; Banjo OO; Laoye A; Adetunmbi B; Adebayo BO; Oluyombo R
Pan Afr Med J; 2017; 27():151. PubMed ID: 28904679
[TBL] [Abstract][Full Text] [Related]
5. Effects of an Educational Program for Prostate Cancer Prevention on knowledge and PSA Testing in Men Over 50 Years old in Community Areas of Shiraz in 2016.
Molazem Z; Ebadi M; Khademian M; Zare R
Asian Pac J Cancer Prev; 2018 Mar; 19(3):633-637. PubMed ID: 29580031
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and characteristics of prostate cancer among participants of a community-based screening in Nigeria using serum prostate specific antigen and digital rectal examination.
Ikuerowo SO; Omisanjo OA; Bioku MJ; Ajala MO; Mordi VP; Esho JO
Pan Afr Med J; 2013; 15():129. PubMed ID: 24255735
[TBL] [Abstract][Full Text] [Related]
7. Prostate cancer awareness and screening practice among Kenyan men.
Erena AN; Shen G; Lei P
Eur J Cancer Prev; 2020 May; 29(3):252-258. PubMed ID: 32243332
[TBL] [Abstract][Full Text] [Related]
8. Awareness and use of the prostate-specific antigen test among African-American men.
Ross LE; Uhler RJ; Williams KN
J Natl Med Assoc; 2005 Jul; 97(7):963-71. PubMed ID: 16080666
[TBL] [Abstract][Full Text] [Related]
9. Prostate cancer screening practices in a large, integrated health system: 2007-2014.
Misra-Hebert AD; Hu B; Klein EA; Stephenson A; Taksler GB; Kattan MW; Rothberg MB
BJU Int; 2017 Aug; 120(2):257-264. PubMed ID: 28139034
[TBL] [Abstract][Full Text] [Related]
10. Prostate cancer screening: Knowledge, attitudes and practices in a sample of men in Italy. A survey.
Morlando M; Pelullo CP; Di Giuseppe G
PLoS One; 2017; 12(10):e0186332. PubMed ID: 29023514
[TBL] [Abstract][Full Text] [Related]
11. Factors influencing Nigerian men's decision to undergo prostate specific antigen testing.
Enaworu OU; Khutan R
Afr Health Sci; 2016 Jun; 16(2):524-32. PubMed ID: 27605968
[TBL] [Abstract][Full Text] [Related]
12. Factors influencing primary care physicians' decision to order prostate-specific antigen (PSA) test for men without prostate cancer.
Hayat Roshanai A; Nordin K; Berglund G
Acta Oncol; 2013 Nov; 52(8):1602-8. PubMed ID: 23421929
[TBL] [Abstract][Full Text] [Related]
13. GP and patient predictors of PSA screening in Australian general practice.
Gattellari M; Young JM; Ward JE
Fam Pract; 2003 Jun; 20(3):294-303. PubMed ID: 12738699
[TBL] [Abstract][Full Text] [Related]
14. National Prostate Cancer Screening Rates After the 2012 US Preventive Services Task Force Recommendation Discouraging Prostate-Specific Antigen-Based Screening.
Drazer MW; Huo D; Eggener SE
J Clin Oncol; 2015 Aug; 33(22):2416-23. PubMed ID: 26056181
[TBL] [Abstract][Full Text] [Related]
15. Do Men Receive Information Required for Shared Decision Making About PSA Testing? Results from a National Survey.
Leyva B; Persoskie A; Ottenbacher A; Hamilton JG; Allen JD; Kobrin SC; Taplin SH
J Cancer Educ; 2016 Dec; 31(4):693-701. PubMed ID: 26498649
[TBL] [Abstract][Full Text] [Related]
16. Determinants of receipt of prostate cancer screening among men living with HIV enrolled in an urban HIV Clinic in the United States over the period of 2000-2020.
Pirsl F; Keruly JC; Moore RD; Lau B; Joshu CE
Prev Med; 2024 Jul; 184():108000. PubMed ID: 38735585
[TBL] [Abstract][Full Text] [Related]
17. Awareness and Attitudes of Nigerian Men Living in Abuja on Prostate Cancer and Screening.
Farazi PA; Siahpush M; Maloney S; Dinkel D; Michalek A; John R; Oluwole O
J Cancer Educ; 2019 Dec; 34(6):1107-1111. PubMed ID: 30116988
[TBL] [Abstract][Full Text] [Related]
18. Use of low free to total PSA ratio in prostate cancer screening: detection rates, clinical and pathological findings in Brazilian men with serum PSA levels <4.0 ng/mL.
Faria EF; Carvalhal GF; dos Reis RB; Tobias-Machado M; Vieira RA; Reis LO; Nogueira L; Machado RD; Freitas CH; Magnabosco WJ; Mauad EC; Carvalho AL
BJU Int; 2012 Dec; 110(11 Pt B):E653-7. PubMed ID: 22892057
[TBL] [Abstract][Full Text] [Related]
19. Lifetime and recent prostate specific antigen (PSA) screening of men for prostate cancer in Canada.
Beaulac JA; Fry RN; Onysko J
Can J Public Health; 2006; 97(3):171-6. PubMed ID: 16827400
[TBL] [Abstract][Full Text] [Related]
20. National trends in prostate cancer screening among older American men with limited 9-year life expectancies: evidence of an increased need for shared decision making.
Drazer MW; Prasad SM; Huo D; Schonberg MA; Dale W; Szmulewitz RZ; Eggener SE
Cancer; 2014 May; 120(10):1491-8. PubMed ID: 24523016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
